Should We Measure Biomarkers for Myonecrosis Before and After PCI?
J Am Coll Cardiol
.
2016 Nov 29;68(21):2269-2271.
doi: 10.1016/j.jacc.2016.08.057.
Author
Sorin J Brener
1
Affiliation
1
Cardiac Catheterization Laboratory, New York Methodist Hospital, Brooklyn, New York. Electronic address: sjb9005@nyp.org.
PMID:
27884244
DOI:
10.1016/j.jacc.2016.08.057
No abstract available
Keywords:
coronary artery disease; high-sensitivity troponin T; myocardial infarction.
Publication types
Editorial
Comment
MeSH terms
Angioplasty, Balloon, Coronary
Biomarkers*
Humans
Muscular Diseases
Necrosis
Percutaneous Coronary Intervention*
Substances
Biomarkers